Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > number 1

<< Previous

Bullboard Posts

Next >>

Comment by Sailboatdreamon May 05, 2022 6:35am

132 Views

Post# 34657709

RE:number 1

Good morning Charly. Number 1 with what? The functional cure and solution? Ok - we agree. But they certainly are not number 1 in terms of communication, investor relations, deal making, ensuring shareholder value.

Even JW - one of the biggest Sernova supporters - announced yesterday that he was getting out.

not only is SVA IR unable to convince new money to invest, they are unable to convince strong supporters to stay.

SVA management have a great solution. And they don't know what to do with it.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario